NUVATION BIO INC (NUVB:NYSE)
$6.33 -0.37 (-5.5224%)
Analysed NUVATION BIO INC (NUVB:NYSE) News Sources
Can Nuvation Bio Inc (NUVB) Stock Soar 150% From Current Level?
13-07-2026
yahoo.com
RBC Capital Cuts PT on Nuvation Bio (NUVB) in Q2 Preview
15-07-2026
yahoo.com
Nuvation Bio Announces Positive Updated Phase 2 Data and Expansion of Safusidenib Clinical Program with Two New Studies to Explore Broad Spectrum of IDH1-Mutant Glioma
20-07-2026
yahoo.com
NUVB Stock Is Soaring Today — Why RBC Sees $3B Opportunity In Nuvation Bio's Brain Cancer Drug
20-07-2026
stocktwits.com
Sector Update: Healthcare Stocks Fall Late Afternoon
20-07-2026
yahoo.com
Nuvation Bio (NUVB) Soars 7.9%: Is Further Upside Left in the Stock?
21-07-2026
yahoo.com
Nuvation Bio's Safusidenib Clinical Program, Ibtrozi Opportunity Create Favorable Setup, RBC Says
22-07-2026
yahoo.com
Nuvation Bio to Report Second Quarter 2026 Financial Results and Provide Business Update on August 6, 2026
22-07-2026
yahoo.com
Wall Street Analysts See a 94.32% Upside in Nuvation Bio (NUVB): Can the Stock Really Move This High?
29-07-2026
yahoo.com
Nuvation Bio Inc. (NUVB) Expected to Beat Earnings Estimates: Should You Buy?
30-07-2026
yahoo.com
What is the current price of NUVATION BIO INC (NUVB:NYSE)?
The current price of NUVATION BIO INC (NUVB:NYSE) is $6.33.
NUVATION BIO INC (NUVB:NYSE) absolute price change since previous trading day?
The absolute price change of NUVATION BIO INC (NUVB:NYSE) since the previous trading day is $-0.37.
NUVATION BIO INC (NUVB:NYSE) percentage price change since previous trading day?
The percentage price change of NUVATION BIO INC (NUVB:NYSE) since the previous trading day is -5.5224%.
What is the most recent average sentiment score for NUVATION BIO INC (NUVB:NYSE)?
The most recent average sentiment score for NUVATION BIO INC (NUVB:NYSE) is 78 out of 100.
What is the most recent average sentiment for NUVATION BIO INC (NUVB:NYSE)?
The most recent sentiment for NUVATION BIO INC (NUVB:NYSE) is .
SEC-8K** Filing Available For NUVATION BIO INC (NUVB:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.